Literature DB >> 28628303

Folate and Heptamethine Cyanine Modified Chitosan-Based Nanotheranostics for Tumor Targeted Near-Infrared Fluorescence Imaging and Photodynamic Therapy.

Yingying Zhang1, Tingting Lv1, Huijuan Zhang1, Xiaodong Xie1, Ziying Li1, Haijun Chen1, Yu Gao1.   

Abstract

Folate (FA) and heptamethine cyanine (Cy7)-modified chitosan (CF7) was synthesized by click chemistry and its self-assembled nanoparticles (CF7Ns) were developed for tumor-specific imaging and photodynamic therapy. The characterization spectrum confirmed CF7 had a good FA and Cy7 conjugation efficacy. The diameter of CF7Ns measured by DLS was about 291.6 nm, and the morphology observed with AFM showed filamentous clusters of particles. The results of targeting ability of CF7Ns demonstrated enhanced targeting behaviors of CF7Ns compared with non-FA-modified nanoparticles C7Ns in FA receptor-positive HeLa cells. The cytotoxicity and cell apoptosis assay showed that CF7Ns under near-infrared light irradiation led to more apoptotic cell death in HeLa cells to improve the therapeutic efficacy. The mechanisms of the photodynamic effects of CF7Ns were demonstrated through measurement of intracellular reactive oxygen species and the apoptosis-related cytokines. These results suggested that CF7Ns are promising tumor targeting carriers for simultaneous fluorescence imaging and photodynamic therapy.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28628303     DOI: 10.1021/acs.biomac.7b00466

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  2 in total

1.  Synthesis and potent cytotoxic activity of a novel diosgenin derivative and its phytosomes against lung cancer cells.

Authors:  Liang Xu; Dekang Xu; Ziying Li; Yu Gao; Haijun Chen
Journal:  Beilstein J Nanotechnol       Date:  2019-09-24       Impact factor: 3.649

Review 2.  Heptamethine Cyanine-Based Application for Cancer Theranostics.

Authors:  Lei Zhang; Hang Jia; Xuqian Liu; Yaxin Zou; Jiayi Sun; Mengyu Liu; Shuangshuang Jia; Nan Liu; Yanzhang Li; Qun Wang
Journal:  Front Pharmacol       Date:  2022-02-11       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.